People

  1. Hoover
    Hoover
  2. Hirschhorn Cymerman
    Hirschhorn Cymerman
  3. Licciardi
    Licciardi
  4. Mazo
    Mazo
  5. Ng
    Ng
  6. Windner
    Windner
  7. Mukherjee
    Mukherjee
  8. Uprety
    Uprety
  9. Michalski
    Michalski
  10. Van Der Ploeg
    Van Der Ploeg
  11. Horiates Spatz
    Horiates Spatz
  12. Segal
    Segal
  13. Murakami
    Murakami
  14. Patel
    Patel
  15. Houlihan
    Houlihan

Recent Works

  1. Patient-centered outcomes in ARIEL3, a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma
    Meeting Abstract

    Bedel, D. J.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; Leary, A.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  2. Quality adjusted time without symptoms of disease progression or toxicity (Q-TWIST) of nivolumab plus ipilimumab (NIVO+IPI) vs sunitinib (SUN) among untreated advanced renal cell carcinoma (ARCC) patients (patients) with intermediate or poor prognostic risk
    Meeting Abstract

    Shah, R.; Botteman, M.; Kwon, Y.; Gooden, K. M.; Cella, D.; Motzer, R.
    Value in Health (2019)

    Fulltext@MSK | Save
  3. Cost-effectiveness of a 24-month fixed duration of venetoclax in combination with rituximab in relapsed or refractory chronic lymphocytic leukemia in the United States
    Meeting Abstract

    Huntington, S. F.; Strunz-McKendry, T.; Masaquel, A. S.; Shapouri, S.; Sail, K.; Durno, N.; Mato, A.
    Value in Health (2019)

    Fulltext@MSK | Save